|
1
|
Doorbar J: Molecular biology of human
papillomavirus infection and cervical cancer. Clin Sci (Lond).
110:525–541. 2006. View Article : Google Scholar
|
|
2
|
zur Hausen H: Papillomaviruses and cancer:
From basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rosenzwieg SA and Atreya HS: Defining the
pathway to insulin-like growth factor system targeting in cancer.
Biochem Pharmacol. 80:1115–1124. 2010. View Article : Google Scholar
|
|
4
|
Baserga R: Customizing the targeting of
IGF-1 receptor. Future Oncol. 5:43–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weroha SJ and Haluska P: The insulin-like
growth factor system in cancer. Endocrinol Metab Clin North Am.
41:335–350. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Laron Z, Steuerman R and Shevah O: Laron
Syndrome patients with congenital IGF-I deficiency seem protected
from malignant diseases. Laron Syndrome - From Man to Mouse. Laron
Z and Kopchich J: Springer-Verlag; Berlin Heidelberg: pp. 339–340.
2011, View Article : Google Scholar
|
|
7
|
Grimberg A and Cohen P: Role of
insulin-like growth factors and their binding proteins in growth
control and carcinogenesis. J Cell Physiol. 183:1–9. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pollak MN: Insulin and insulin-like growth
factor signaling in neoplasia. Nat Rev Cancer. 12:915–928. 2008.
View Article : Google Scholar
|
|
9
|
Rotwein P, Pollock KM, Didier DK and Krivi
GG: Organization and sequence of the human insulin-like growth
factor I gene. J Biol Chem. 261:4828–4832. 1986.PubMed/NCBI
|
|
10
|
Adamo ML, Neuenschwander S, LeRoith D, et
al: Structure, expression and regulation of the IGF-I gene. Adv Exp
Med Biol. 343–351. 1993.
|
|
11
|
Yu H, Li B, Smith M, et al: Polymorphic CA
repeats in the IGF-I gene and breast cancer. Breast Cancer Res
Treat. 70:117–122. 2001. View Article : Google Scholar
|
|
12
|
Wong HL, Delellis K, Probst-Hensch N, et
al: A new single nucleotide polymorphism in the insulin-like growth
factor I regulatory region associates with colorectal cancer risk
in Singapore Chinese. Cancer Epidemiol Biomarkers Prev. 14:144–151.
2005.PubMed/NCBI
|
|
13
|
Chen X, Guan J, Song Y, et al: IGF I (CA)
repeat polymorphism and risk of cancer: a meta analysis. J Hum
Genet. 53:227–238. 2008. View Article : Google Scholar
|
|
14
|
Pacholska-Bogalska J, Jozefiak A, Nowak W,
et al: Association of the IGF-I promoter P1 polymorphism with risk
of cervical cancer. Eur J Gynaecol Oncol. 32:393–398.
2011.PubMed/NCBI
|
|
15
|
Tavassoli FA and Deville P: World Health
Organization Classification of Tumors. Pathology, Genetics. Tumours
of the Breast and Female Genital Organs. IRAC Press; Lyon: 2003
|
|
16
|
Benedet JL, Bender H, Jones H, Ngan HY and
Pecorelli S: FIGO staging classifications and clinical practice
guidelines in the management of gynecologic cancers. FIGO Committee
on Gynecologic Oncology. Int J Gynaecol Obstet. 70:209–262. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Manos MM, Ting Y, Wright DK, et al: The
use of polymerase chain reaction amplification for the detection of
genital human papillomaviruses. Cancer Cell. 7:209–214. 1989.
|
|
18
|
Nakagawa K, Yamamura K, Maeda S and
Ichihashi M: Bcl-2 expression in epidermal keratinocytic diseases.
Cancer. 74:1720–1724. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Serre D, Gurd S, Ge B, et al: Differential
allelic expression in the human genome: a robust approach to
identify genetic and epigenetic cis-acting mechanisms regulating
gene expression. PLoS Genet. 4:e10000062008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Keku TO, Vidal A, Oliver S, et al: Genetic
variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon
cancer risk in African Americans and Whites. Cancer Causes Control.
23:1127–1138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dean JP, Sprenger CC, Wan J, et al:
Response of the insulin-like growth factor (IGF) system to IGF-IR
inhibition and androgen deprivation in a neoadjuvant prostate
cancer trial: effects of obesity and androgen deprivation. J Clin
Endocrinol Metab. 98:E820–E828. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsilidis KK, Travis RC, Appleby PN, et al:
Insulin-like growth factor pathway genes and blood concentrations,
dietary protein and risk of prostate cancer in the NCI Breast and
Prostate Cancer Cohort Consortium (BPC3). Int J Cancer. 15:495–504.
2013. View Article : Google Scholar
|
|
23
|
Wang Z, Wang Z, Liang Z, et al: Expression
and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum
and lung cancer tissues from patients with non-small cell lung
cancer. Onco Targets Ther. 6:1437–1444. 2013.PubMed/NCBI
|
|
24
|
Savage MO: Insulin-like growth factors,
nutrition and growth. World Rev Nutr Diet. 106:52–59. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen MR, Hsu YM, Hsu KF, et al:
Insulin-like growth factor 1 is a potent stimulator of cervical
cancer cell invasiveness and proliferation that is modulated by
ανβ3 integrin signaling. Carcinogegenesis. 27:962–971. 2006.
View Article : Google Scholar
|
|
26
|
Bruchim I and Werner H: Targeting IGF-1
signaling pathways in gynecologic malignancies. Expert Opin Ther
Targets. 17:307–320. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mannhard B, Weinzimer SA, Wagner M, et al:
Human papillomavirus type 16 E7 oncoprotein binds and inactivates
growth-inhibitory insulin-like growth factor binding protein 3. Mol
Cell Biol. 20:6483–6495. 2000. View Article : Google Scholar
|
|
28
|
Maloney EK, McLaughlin JL, Dagdigian NE,
et al: An anti-insulin-like growth factor I receptor antibody that
is a potent inhibitor of cancer cell proliferation. Cancer Res.
63:5073–5083. 2003.PubMed/NCBI
|
|
29
|
Nakamura K, Hongo A and Kodama J:
Down-regulation of the insulin-like growth factor I receptor by
antisense RNA can reverse the transformed phenotype of human
cervical cancer cell lines. Cancer Res. 60:760–765. 2000.PubMed/NCBI
|
|
30
|
Harris TG, Bruk RD, Yu H, et al: Insulin
like-growth factor axis and oncogenic human papillomavirus natural
history. Cancer Epidemiol Biomarkers Prev. 17:245–248. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee SW, Lee SY, Lee SR, et al: Plasma
levels of insulin-like growth factor-I and insulin-like growth
factor binding protein-3 in women with cervical neoplasia. J
Gynecol Oncol. 21:174–180. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schaffer A, Koushik A, Trottier H, et al:
Insulin-like growth factor-I and risk of high-grade cervical
intraepithelian neoplasia. Cancer Epidemiol Biomarkers Prev.
16:716–722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jozefiak A, Pacholska-Bogalska J,
Myga-Nowak M, et al: Serum and tissue levels of insulin-like growth
factor-I in women with dysplasia and HPV-positive cervical cancer.
Mol Med Report. 1:231–237. 2008.
|
|
34
|
Cleveland RJ, Gammon MD, Edmiston SN, et
al: IGF1 CA repeat polymorphisms, lifestyle factors and breast
cancer risk in the Long Island Breast Cancer Study Project.
Carcinogenesis. 27:758–765. 2006. View Article : Google Scholar
|
|
35
|
Missmer SA, Haiman CA and Hunter DJ: A
sequence repeat in the insulin-like growth factor-1 gene and risk
of breast cancer. Int J Cancer. 100:332–336. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fehringer G, Ozcelik H, Knight JA, et al:
Association between IGF1 CA microsatellites and mammographic
density, anthropometric measures, and circulating IGF-I levels in
premenopausal Caucasian women. Breast Cancer Res Treat.
116:413–423. 2009. View Article : Google Scholar
|
|
37
|
DeLellis K, Ingles S, Kolonel L, et al:
IGF1 genotype, mean plasma level and breast cancer risk in the
Hawaii/Los Angeles multiethnic cohort. British J Cancer.
88:277–282. 2003. View Article : Google Scholar
|
|
38
|
Chen HY, Chan IHS, Sham ALK, et al:
Haplotype effect in the IGF1 promoter accounts for the association
between microsatellite and serum IGF1 concentration. Clin
Endocrinol (Oxf). 74:520–527. 2011. View Article : Google Scholar
|
|
39
|
Jernström H, Sandberg T, Bågeman E, et al:
Insulin-like growth factor-1 genotype predicts breast volume after
pregnancy and hormonal contraception and is associated with
circulating insulin-like growth factor-1 levels: implications for
risk of early-onset breast cancer in young women from hereditary
breast cancer families. Br J Cancer. 14:92:857–866. 2005.
View Article : Google Scholar
|
|
40
|
Costalonga EF, Antonini SR, Guerra G Jr,
et al: Growth hormone pharmacogenetics: the interactive effect of
amicrosatellite in the IGF1 promoter region with the GHR-exon 3
and-202 A/C IGFBP3 variants on treatment outcomes of children with
severe GH deficiency. Pharmacogenomics J. 125:439–445. 2012.
View Article : Google Scholar
|
|
41
|
Hand BD, Kostek MC, Ferrell RE, et al:
Influence of promoter region variants of insulin-like growth factor
pathway genes on the strength-training response of muscle
phenotypes in older adults. J Appl Physiol. 103:1678–1687. 2007.
View Article : Google Scholar : PubMed/NCBI
|
